Genomic Profiling of Intrahepatic Cholangiocarcinoma: Refining Prognosis and Identifying Therapeutic Targets-Reference-Cited by-同舟云学术

Genomic Profiling of Intrahepatic Cholangiocarcinoma: Refining Prognosis and Identifying Therapeutic Targets

Published:2014-06-03 Issue:12 Volume:21 Page:3827-3834
ISSN:1068-9265
Container-title:Annals of Surgical Oncology
language:en
Short-container-title:Ann Surg Oncol

Author:

Zhu Andrew X.,Borger Darrell R.,Kim Yuhree,Cosgrove David,Ejaz Aslam,Alexandrescu Sorin,Groeschl Ryan Thomas,Deshpande Vikram,Lindberg James M.,Ferrone Cristina,Sempoux Christine,Yau Thomas,Poon Ronnie,Popescu Irinel,Bauer Todd W.,Gamblin T. Clark,Gigot Jean Francois,Anders Robert A.,Pawlik Timothy M.

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Surgery

Link

http://link.springer.com/content/pdf/10.1245/s10434-014-3828-x.pdf

Reference34 articles.

1. Shaib YH, Davila JA, McGlynn K, et al. Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase? J Hepatol. 2004;40:472–7.

2. Poultsides GA, Zhu AX, Choti MA, et al. Intrahepatic cholangiocarcinoma. Surg Clin North Am. 2010;90:817–37.

3. Valle J, Wasan H, Palmer DH, et al. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med. 2010;362:1273–81.

4. Hezel AF, Deshpande V, Zhu AX. Genetics of biliary tract cancers and emerging targeted therapies. J Clin Oncol. 2010;28:3531–40.

5. Sia D, Tovar V, Moeini A, et al. Intrahepatic cholangiocarcinoma: pathogenesis and rationale for molecular therapies. Oncogene. 2013;32:4861–70.

Cited by 128 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Factors associated with prognosis and staging of intrahepatic cholangiocarcinoma;Journal of Cancer Metastasis and Treatment;2024-07-10

2. Early Onset Intrahepatic Cholangiocarcinoma: Clinical Characteristics, Oncological Outcomes, and Genomic/Transcriptomic Features;Annals of Surgical Oncology;2024-02-12

3. The heterogeneity of signaling pathways and drug responses in intrahepatic cholangiocarcinoma with distinct genetic mutations;Cell Death & Disease;2024-01-11

4. ARID1A Mutation from Targeted Next-Generation Sequencing Predicts Primary Resistance to Gemcitabine and Cisplatin Chemotherapy in Advanced Biliary Tract Cancer;Cancer Research and Treatment;2023-10-15

5. Review of IDH mutations and potential therapies for intrahepatic cholangiocarcinoma;Hepatoma Research;2023-08-03